ArticleCancers2023

Efficacy of Systemically Administered Retargeted Oncolytic Herpes Simplex Viruses-Clearance and Biodistribution in Naïve and HSV-Preimmune Mice.

Andrea Vannini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.